Skip to content
Home/Companies/MedTech/Route92

Route92

MedTech·US·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Route92?

Route92 is currently owned by Novo Holdings through Novo Holdings Growth Investments (1999 vintage), since 2024.

Hand-verified · updated 2026-08-18

Novo Holdings
Investor
Novo Holdings
Novo Holdings Growth Investments · 1999 · Growth

Key facts

HQUnited States
SectorMedTech
StatusActive

More from Novo Holdings Growth Investments

Other portfolio companies in the same fund.

Surya Hospitals
Active
HealthcareIndia· 2026
Phasecraft
Phasecraft
Active
Deep TechUK· 2025
AvenCell
Active
BiotechUS· 2024
Cleveland Diagnostics
Active
MedTechUS· 2024
Convergent
Active
BiotechUS· 2024
Medi Assist
Active
HealthTechIndia· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Route92

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Route92?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Route92.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue